CVE & CISA-KEV Catalog

CVE-2019-18256

MEDIUM
4.6
CVSS v3
NVD

Description

BIOTRONIK CardioMessenger II, The affected products use individual per-device credentials that are stored in a recoverable format. An attacker with physical access to the CardioMessenger can use these credentials for network authentication and decryption of local data in transit.

CWE-257CWE-522

How to fix

No published remediation has been found for this vulnerability's affected products yet.

Mitigation guidance may be in the linked vendor advisories in the References section below.

CVSS v3 Vector

Exploitability

Attack VectorPhysical
Attack ComplexityLow
Privileges RequiredNone
User InteractionNone
ScopeUnchanged

Impact

ConfidentialityHigh
IntegrityNone
AvailabilityNone

CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Exploit Intelligence

0.36%probability of exploitation in 30 days
28thpercentile

Low risk: more likely to be exploited than 28% of all known CVEs.

References

Third-Party Advisory1
Embed a live status badge for CVE-2019-18256
CVE-2019-18256 severity badge

Markdown

[![CVE-2019-18256](https://tridentstack.com/cve/badge/CVE-2019-18256.svg)](https://tridentstack.com/cve/CVE-2019-18256)

HTML

<a href="https://tridentstack.com/cve/CVE-2019-18256"><img src="https://tridentstack.com/cve/badge/CVE-2019-18256.svg" alt="CVE-2019-18256"></a>

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2024-11-21.